Study guide

3.6 Polysubstance Use and Overdose Triage

IC&RC Alcohol and Drug Counselor CADC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Orientation, IC&RC ADC Exam, and Credential Path

1.1 ADC Credential, IC&RC, and CADC Naming 1.2 Administering Board Application Workflow 1.3 Minimum Standards and Eligibility Boundaries 1.4 ADC Blueprint and Study Priorities 1.5 Exam Format, Items, and Time Management 1.6 Scores, Results, Retakes, and Remediation 1.7 Exam-Day Admission, In-Person Testing, and Remote Testing

2 Chapter 2: Addiction Science, Substance-Use Patterns, and Risk Factors

2.1 Disease Model and Biopsychosocial Frame 2.2 Reward Pathways, Learning, and Reinforcement 2.3 Tolerance, Withdrawal, Craving, and Cross-Tolerance 2.4 Substance-Use Progression and Severity Patterns 2.5 Risk and Protective Factors Across the Lifespan 2.6 Prevention, Case Conceptualization, and Domain Integration

3 Substance Classes, Intoxication, Overdose, and Withdrawal

3.1 Alcohol Intoxication, Overdose, and Withdrawal 3.2 Sedatives, Hypnotics, Anxiolytics, and Cross-Tolerance 3.3 Opioids: Intoxication, Overdose, and Withdrawal 3.4 Stimulants: Intoxication, Crash, and Crisis Risk 3.5 Cannabis, Hallucinogens, and Inhalants 3.6 Polysubstance Use and Overdose Triage

4 Co-Occurring Mental Health, Medical, and Trauma Concerns

4.1 Co-Occurring Symptoms and Integrated Screening 4.2 Suicide, Self-Harm, and Crisis Triage 4.3 Medical Red Flags and Substance-Related Health Concerns 4.4 Trauma-Informed Care and ACEs 4.5 Special Populations, Developmental, and Cultural Factors 4.6 Scope, Referral, Collaboration, and Documentation

5 Screening, Interviewing, and Assessment Instruments

5.1 Motivational Assessment Interview Stance 5.2 Screening Purpose and Instrument Selection 5.3 Substance-Use History and Pattern Exploration 5.4 Collateral Information and Testing Interpretation 5.5 Risk, Withdrawal, and Immediate Needs Screening 5.6 Engagement, Culture, and Documentation

6 Diagnosis, Biopsychosocial Assessment, and Level of Care

6.1 Diagnostic Concepts and Scope 6.2 Biopsychosocial Assessment Framework 6.3 Immediate and Ongoing Needs 6.4 Level-of-Care Placement Reasoning 6.5 Case Formulation and Assessment Summary 6.6 Documentation, Referral, and Reassessment

7 Counseling Relationship, Communication, and Motivational Interviewing

7.1 Rapport and the Working Alliance 7.2 Core Communication Skills 7.3 OARS and Reflective Listening 7.4 Ambivalence, Resistance, and Discord 7.5 Change Talk and Stages of Change 7.6 Feedback and Counselor Style

8 Treatment Planning, Case Management, and Referral

8.1 Treatment Plan Anatomy 8.2 Individualized Goals and Objectives 8.3 Relapse Prevention and Continuing Care 8.4 Case Management and Resource Linkage 8.5 Referral and Multidisciplinary Collaboration 8.6 Discharge, Termination, and Continuity of Care

9 Group Counseling, Family Work, and Recovery Pathways

9.1 Group Purpose, Screening, and Norms 9.2 Group Stages, Cohesion, and Facilitation Skills 9.3 Psychoeducation, Skills Groups, and Process Groups 9.4 Family and Support-System Collaboration 9.5 Mutual Help, Peer Support, and Recovery Pathways 9.6 Medication, Culture, and Continuing Care

10 Professional Ethics, Boundaries, and Scope of Practice

10.1 Ethical Frameworks and Decision Making 10.2 Boundaries, Dual Relationships, and Power 10.3 Self-Disclosure, Conflicts of Interest, and Gifts 10.4 Scope of Practice, Competence, and Referral 10.5 Supervision, Consultation, and Team Accountability 10.6 Self-Awareness, Impairment, and Burnout

11 Confidentiality, Documentation, Informed Consent, and Client Rights

11.1 Confidentiality Foundations for ADC Practice 11.2 Releases and Minimum Necessary Disclosure 11.3 Documentation and Record Quality 11.4 Informed Consent and Client Rights 11.5 Mandated Reporting and Safety Exceptions 11.6 Grievances, Records, Storage, and Professional Communication

12 Integrated CADC Case Scenarios and Final Review

12.1 Reading Integrated Case Vignettes 12.2 Blueprint-Weighted Final Review 12.3 Integrated Scenario: First Contact Through Assessment 12.4 Integrated Scenario: Treatment, Referral, and Discharge 12.5 Weak-Domain Remediation and 8-12 Week Study Plan 12.6 Exam Day, Results, and Retake Workflow

3.6 Polysubstance Use and Overdose Triage

Key Takeaways Explain This Topic AI

Polysubstance use mixes signs, masks impairment, and multiplies overdose and withdrawal risk — depressant combinations are the deadliest.

Stacked CNS depressants (alcohol + benzodiazepines + opioids) cause additive-to-multiplicative respiratory depression.

Triage uses observable facts first: airway, breathing, consciousness, orientation, and red flags — before identifying the exact drug.

Remember the asymmetry: CNS-depressant withdrawal can be lethal, while opioid and stimulant overdose are the lethal intoxication events.

When the substance is unknown, assess observable risk, follow emergency policy, document facts, consult, and refer.

Last updated: June 2026

Polysubstance use: mixed signs, one best answer

Polysubstance use means using more than one substance in the same period — planned or accidental. On the ADC exam it appears as a confusing case stem: alcohol with benzodiazepines, opioids with alcohol, stimulants chased by depressants, cannabis with unknown pills, or fentanyl contamination of another supply. The skill is not to guess a perfect toxicology answer; it is to notice immediate risk, ask focused questions, and act within CADC scope. Mixed substances change expected signs, mask impairment, and multiply overdose or withdrawal danger .

The most dangerous principle is stacked CNS depression . Alcohol, benzodiazepines, barbiturates, opioids, and GHB all depress breathing; together their effects are additive to multiplicative , not simply additive. This is why benzodiazepines and alcohol are found in a large share of opioid-overdose deaths.

  • Mixed pattern Why it matters CADC response
  • Alcohol + sedatives Compounded CNS depression Assess breathing and alertness; emergency if impaired
  • Opioids + alcohol/benzos Multiplied overdose risk Emergency protocol; naloxone for opioid component
  • Stimulants + alcohol (cocaethylene) Cardiac strain, prolonged toxicity Assess medical red flags
  • "Speedball" (stimulant + opioid) Opposing signs mask overdose High risk; treat depressant danger
  • Unknown pills Uncertain dose/contents Do not reassure falsely

Note cocaethylene — a metabolite formed in the liver only when cocaine and alcohol are used together — increases cardiac toxicity, lasts longer than cocaine alone, and is a testable polysubstance fact. The speedball (opioid plus stimulant, e.g., heroin and cocaine) is especially deceptive: the stimulant can mask the sedation and slowed breathing of the opioid, so the user does not realize they are overdosing, and when the short-acting stimulant wears off first, the opioid depression deepens. The exam point is that opposing-direction combinations hide danger rather than cancel it out.

Triage with observable facts and the danger asymmetry

Immediate triage relies on observable facts before drug identification . Run the questions in order:

Airway / breathing — is the client breathing normally, or slow/shallow/gurgling?

Consciousness — awake, drowsy, or unrousable?

Orientation — knows person, place, time, situation?

Red flags — chest pain, seizure, head injury, suicidal/violent intent, severe confusion, very high temperature?

Mobility/safety — can the client walk and stay safe?

These guide action even when the exact substance is unknown . Treat breathing problems, unconsciousness, chest pain, seizure, severe confusion, or suicidal intent as urgent.

The exam loves the danger asymmetry , so keep it crisp:

Drug class Lethal at intoxication/overdose? Lethal in withdrawal?

  • Alcohol Yes (poisoning) Yes — seizures, DTs
  • Sedative-hypnotics Barbiturates yes; combos yes Yes — seizures, delirium
  • Opioids Yes — respiratory depression Rarely (distressing, not usually lethal)
  • Stimulants Yes (cardiac, stroke, hyperthermia) No (crash; suicide risk)

So: CNS-depressant withdrawal can kill; opioid and stimulant overdose can kill. That single sentence resolves many one-best-answer items, because the test repeatedly checks whether you reach for emergency response in the right scenario rather than applying the same plan to every drug class.

Scope, documentation, and exam traps

Polysubstance cases touch all four ADC domains. Assessment identifies substances and risk; counseling addresses ambivalence and patterns; case management/referral links care; and engagement/professional responsibility covers overdose education and safer planning within agency policy.

Applied scenario: a client reports using heroin, alcohol, and sleeping pills before the appointment and is nodding and hard to arouse. The best answer is emergency action and supervision per policy, with naloxone for the opioid component if trained — because three CNS depressants are stacked. A routine relapse analysis can wait until the client is medically stable.

" Assess both stimulant and alcohol risks, sleep deprivation, mood, withdrawal history, and unsafe behaviors; plan for triggers, safer supports, medical referral, and provider coordination.

Documentation records substance names as reported, route, amount, last use, observed impairment, safety concerns per procedure, consultation, referral, and client response. Keep it factual; if later toxicology differs from self-report, update records per policy.

Exam traps:

Choosing a single-drug answer when the stem clearly lists multiple substances.

Assuming a client is exaggerating because signs do not fit one clean drug class — mixed use makes mixed presentations.

Trying to set level of care from one intoxication fact — placement reasoning belongs to full assessment; first stabilize and refer, then complete the biopsychosocial picture.

Forgetting that naloxone reverses only the opioid component of a mixed overdose — depressant effects from alcohol or benzodiazepines persist, so monitoring and EMS are still required.

Quick triage list:

Treat breathing problems, unconsciousness, chest pain, seizure, severe confusion, or suicidal intent as urgent.

Ask about alcohol, sedatives, opioids, stimulants, cannabis, inhalants, and unknown products.

Consider withdrawal risk — especially depressant withdrawal — when a client stops multiple substances.

Do not provide detox instructions outside your role; use supervision, referral, and emergency systems early.

Layer overdose-prevention education into care: naloxone access, never using alone, and the danger of mixing depressants.